News Post List
Cutting out certain amino acids – the building blocks of proteins – from the diet of mice slows tumour growth and prolongs survival.
CRT pioneer fund, Cancer Research UK and NCI collaborate to boost research against the ‘undruggable’ RAS
Cancer Research UK and the Cancer Research Technology Pioneer Fund have committed £2.5 million in collaboration with the National Cancer Institute.
This entry is part 13 of 13 in the series Grand ChallengeIt’s a cliché, but prevention really is better than cure. We often talk of more than 4 in 10 cancers being...
Find out how our scientists are developing a way to target a troublesome cancer molecule, LOX.
News digest – immunotherapies showing promise, breast cancer drug approved for Scotland, childhood cancer rates, and… killer sofas?
Immunotherapies are showing promise but not for every tumour, calls for boys to be vaccinated against HPV, and... what's killer about sofas? Find out in the news digest....
Cancer living outside the body, unravelling a cellular mystery and targeting ‘sleeping’ cancer cells: our latest cutting-edge science projects
Our rapid turn-around funding scheme aims to fund high-risk research that we wouldn’t normally fund.
At AACR 2017, thousands of doctors and scientists shared progress in cancer research. Read about the hottest topics.
Immunotherapy treatment could be improved by blocking molecules that help tumour blood vessels grow, according to two new lab-based studies.
Matching tumour size to the body’s immune response could help doctors tailor immunotherapy treatments for melanoma patients whose disease has spread.
An immunotherapy drug is too expensive to be given to NHS patients with head and neck cancers in England, according to the NHS drugs watchdog.